Document Detail


Which route of misoprostol application is more advantageous prior to fractional curettage in postmenopausal patients?
MedLine Citation:
PMID:  18773214     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To determine the effectiveness and potential side effects of oral, vaginal, and sublingual intake of misoprostol on cervical dilatation prior to fractional curettage in patients with postmenopausal bleeding. METHODS: Seventy-six patients with postmenopausal bleeding during a period of 18 months were included in this randomized controlled trial. Patients were given 400 microg of misoprostol through the vaginal, oral, and sublingual routes, 12 h prior to the fractional curettage procedure. The degree of cervical dilatation, duration of the procedure, the side effects and complications were noted. RESULTS: When compared with the control group, misoprostol administered orally or sublingually was found to have a significant effect on cervical dilatation (P < 0.05). Of the three groups, nausea was found to be more common in the orally administered misoprostol group. CONCLUSIONS: We conclude that the oral or sublingual application of misoprostol prior to fractional curettage in patients with postmenopausal bleeding decreases the need for cervical dilatation.
Authors:
Muge Temel; Fikret Gokhan Goynumer; Lale Wetherilt; Birol Durukan
Related Documents :
15511764 - The management of cervical incompetence with protruded membranes into the vagina by vag...
19757334 - Effects of acupressure at the sanyinjiao point (sp6) on the process of active phase of ...
25379594 - Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravagin...
18196194 - Anatomical and functional results of mccall culdoplasty in the prevention of enterocele...
22943144 - Clinical characteristics, management, and functional outcomes in chinese patients withi...
22259284 - Ptychoptera deleta novák, 1877 from the early miocene of the czech republic: redescript...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2008-09-05
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  279     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-03-26     Completed Date:  2009-06-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  637-42     Citation Subset:  IM    
Affiliation:
Obstetrics and Gynecology Department, Istanbul Goztepe Education and Research Hospital, Goztepe, Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intravaginal
Administration, Sublingual
Dilatation and Curettage*
Drug Administration Routes
Female
Humans
Middle Aged
Misoprostol / administration & dosage*
Oxytocics / administration & dosage*
Postmenopause*
Preoperative Care / methods*
Chemical
Reg. No./Substance:
0/Oxytocics; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transgenic expression of S100A2 in hairless mouse skin enhances Cxcl13 mRNA in response to solar-sim...
Next Document:  Evaluation of outpatient cystoscopy in urogynaecology.